Tuberculosis

TB · Infectious Disease · 2 drugs · 2 indications

Bacterial infection caused by Mycobacterium tuberculosis, primarily affecting the lungs. MDR-TB requires extended treatment with second-line agents.

Competitive Landscape (2 drugs)

Drug	Company	Mechanism	Modality	Route	Stage
Quabodepistat	4578	DprE1 Inhibitor	Small molecule	ORAL	PHASE3
Deltyba	4578	Mycolic Acid Synthesis Inhibitor	Small molecule	ORAL	APPROVED

Indications (2)

MDR Tuberculosis

Deltyba APPROVED

Tuberculosis, drug-susceptible

Data from Supabase · Updated 2026-03-24